The largest exporter of home textiles from Pakistan has recently joined forces with international retailers and manufacturers to establish the Sustainable Textile Coalition. Launched in February 2013 in New York, the coalition aims to ...
Tags: Textile Mills, Textile
The European Commission has approved Sanofi Pasteur's 6-in-1 pediatric vaccine Hexyon/Hexacima (DTaP-IPV-Hib-HepB vaccine) for primary and booster vaccination of infants from six weeks of age. The EC decision follows the European ...
Tags: Pediatric Vaccine, Medicine
What is a Carcinogen? A carcinogen is any substance that can directly cause cancer in living tissue. Radioactive substances are considered to be carcinogens, as well as none -radioactive carcinogens, which include tobacco smoke, dioxins, ...
Janssen Research & Development is seeking US FDA approval for the use of Simeprevir (TMC435) in combination with pegylated interferon and ribavirin to treat genotype 1 chronic hepatitis C in adults. The company submitted a new drug ...
Tags: Health, Medicine, pegylated interferon
Biopharmaceutical company Pfizer has decided to discontinue the development of filibuvir, an experimental hepatitis C drug, following a strategic review and capital allocation. The drug, which is in mid-stage clinical testing, is facing ...
Tags: Pfizer, filibuvir drug, drug
US-based biopharmaceutical company Spring Bank Pharmaceuticals has closed a $10.5m Series A financing round from Brock Securities with Gilford Securities as a participator. The firm is planning to invest the fund in its Phase I clinical ...
The US Food and Drug Administration (FDA) has approved labeling changes to Bristol-Myers Squibb's Reyataz (atazanavir), an antiretroviral medication. The label will now include warnings about kidney and gall stones in addition to updated ...
Inovia Pharmaceuticals will move its hepatitis C DNA vaccine into a phase 1/11a clinical trial by the end of 2013. The advancement of this work is based on exceptional results of a preclinical study, which showed for the first time that a ...
Tags: Inovia Pharmaceuticals, hepatitis C DNA vaccine, clinical trial, 2013
bioMérieux has recently launched the new CE-marked VIDAS® Anti-HCV test for the detection of antibodies to the hepatitis C virus (HCV), extending the Company’s current product range to provide a complete test menu for ...
Tags: Anti HCV Test, Viral Hepatitis, immunoassay platform, fluorescent assay
The adverse side effects of some medications for hepatitis C can now be observed and studied in laboratory conditions, using petri dishes and test tubes, thanks to the development of a new method by US researchers. A team led by Craig ...
Tags: anti-HCV treatments, hepatitis, disease, PLOS Pathogens
The Israel's Ministry of Health (MOH) has granted approval to Medgenics to initiate two Phase I/II clinical trials of a subcutaneous autologous tissue implant, INFRADURE, in patients with hepatitis C. The objective of the trials is to ...
Tags: MOH, clinical trial, medical research
Health Canada has approved Roche's fully automated test, designed to assess a patient's viral load of cytomegalovirus (CMV). The COBAS AmpliPrep / COBAS TaqMan CMV assay is the first approved test, which is standardized to the WHO ...
Tags: Health Canada, CMV, clinical trial
Roche is planning to invest CHF240m ($259m) to construct a new diagnostics production facility at its Penzberg biotechnology center in Munich, Germany. The new 26,000ft2 plant, which will be known as Diagnostics Operations Complex II ...
Advanced Biological Laboratories (ABL) has received CE mark approval for its DeepChek and ViroScore Suite clinical genotyping solutions. The approval is based on several evaluations of the company's next generation sequencing (NGS) ...
Tags: Advanced Biological, ABL, CE mark approval, evaluations
The Food and Drug Administration (FDA) has accepted Dynavax Technologies' heplisav biologics license application (BLA) for immunization against infection caused by all known subtypes of hepatitis B virus in adults 18 through 70 years of ...